[go: up one dir, main page]

Stanton, 2015 - Google Patents

Development of tumour imaging and therapy strategies utilising unengineered bacteria

Stanton, 2015

View PDF
Document ID
4681176129447681099
Author
Stanton R
Publication year

External Links

Snippet

The ability of systemically administered bacteria to target and replicate to high numbers within solid tumours is well established. Tumour localising bacteria can be exploited as biological vehicles for the delivery of nucleic acid, protein or therapeutic payloads to tumour …
Continue reading at cora.ucc.ie (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
    • A61K49/0045—Fluorescence in vivo characterised by the fluorescent group the fluorescent agent being a peptide or protein used for imaging or diagnosis in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving luciferase

Similar Documents

Publication Publication Date Title
Cronin et al. Bacterial vectors for imaging and cancer gene therapy: a review
Cronin et al. High resolution in vivo bioluminescent imaging for the study of bacterial tumour targeting
Liu et al. Brightening up biology: advances in luciferase systems for in vivo imaging
Yu et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins
Mezzanotte et al. In vivo molecular bioluminescence imaging: new tools and applications
De Almeida et al. In vivo bioluminescence for tracking cell fate and function
Kim et al. In vivo cell tracking with bioluminescence imaging
Jiang et al. Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent
Doyle et al. Technoreview: In vivo bioluminescence imaging for integrated studies of infection
Min et al. Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli
JP5696947B2 (en) Use of bacterial beta-lactamase in in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
Tanniche et al. Engineered live bacteria as disease detection and diagnosis tools
Lehouritis et al. Activation of multiple chemotherapeutic prodrugs by the natural enzymolome of tumour-localised probiotic bacteria
Yeh et al. Identification of factors complicating bioluminescence imaging
Bhaumik et al. Noninvasive optical imaging of nitroreductase gene-directed enzyme prodrug therapy system in living animals
Daniel et al. Dual-color bioluminescence imaging for simultaneous monitoring of the intestinal persistence of Lactobacillus plantarum and Lactococcus lactis in living mice
Youn et al. In vivo noninvasive small animal molecular imaging
GM Gahan The bacterial lux reporter system: applications in bacterial localisation studies
Stanton et al. In vivo bacterial imaging without engineering; a novel probe-based strategy facilitated by endogenous nitroreductase enzymes
US20110020240A1 (en) Use of bacterial beta-lactamase for in vitro diagnostics and in vivo imaging, diagnostics and therapeutics
Jiang et al. Bacteria-based live vehicle for in vivo bioluminescence imaging
Brock Application of bioluminescence imaging for in vivo monitoring of fungal infections
Gaikwad et al. Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models
Chu et al. Bacterial imaging in tumour diagnosis
Stanton Development of tumour imaging and therapy strategies utilising unengineered bacteria